NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1538102686 M.D.
Verify on CMS → Manveen Duggal, M.D.
Endocrinology, Diabetes & Metabolism Physician in Dover, Delaware.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 411 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
33%
generic claims · 57% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.3/100
▲ 10 pts above national avg 83.1 · Exceptional
Industry payments
$1.0K
12 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Manveen Duggal, M.D. reported a CMS MIPS final score of 93.3/100 - above the 83.1 national average - and filed 3,145 Medicare Part D claims in 2023.
- 93.3/100
- MIPS score · +10 vs avg
- 3K
- Part D claims, 2023
- 33%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Manveen Duggal, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
93 Top 29% higher than 71% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Manveen Duggal, M.D. sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Manveen Duggal, M.D. writes more Part D claims than 60% of them and scores higher on MIPS quality than 74% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Manveen Duggal, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Manveen Duggal, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Manveen Duggal, M.D.?
High performer (top quartile)Primary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
3,145 19% vs specialty avg
MIPS final score
93.3/100 10.2 pts vs avg
Specialty distribution in Delaware
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Delaware providers
Medicare quality performance, MIPS
Manveen Duggal, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 93.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 93.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Manveen Duggal, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 111 WOLF CREEK BLVD STE 3, Dover, DE, 19901, with a listed phone of (302) 734-2782. NPI 1538102686 was issued on 06/14/2006.
Medicare Part D records for calendar year 2023 show 3,145 prescription claims written by this provider, covering 411 Medicare beneficiaries and totaling roughly $2.6 million in drug spend, split 57% brand-name and 33% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.3/100 for the 2023 performance year (Quality 96.6), compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1538102686 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/14/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
93.2518
Final Score
Avg: 83.1
96.6433
Quality
78
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Manveen Duggal, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.0K
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Manveen Duggal, M.D. - brand share 57.0%
Endocrinology, Diabetes & Metabolism Physician average
57% brand-name claims vs 33% generic, on 3,145 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
3,145
Total Claims
$2.6M
Total Drug Cost
411
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 7,729
- Total Day Supply
- 229,848
- Brand vs Generic
- 57% brand / 33% generic
- Brand Drug Cost
- $2.5M
- Generic Drug Cost
- $34K
Patient Demographics
- Average Patient Age
- 71.7 years
- Avg HCC Risk Score
- 1.74
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 58, 65-74: 186, 75-84: 143, 85+: 24
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Manveen Duggal, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
393 claims
- Ozempic
Ozempic
260 claims
- Trulicity
Trulicity
231 claims
- Jardiance
Jardiance
200 claims
- Metformin Hcl Er
Metformin Hcl Er
173 claims
- Metformin Hcl 137
Metformin Hcl
137 claims
- Novolog Mix 70-30 … 105
Novolog Mix 70-30 Flexpen
105 claims
- Synthroid 77
Synthroid
77 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 393 |
| Ozempic Semaglutide | 260 |
| Trulicity Dulaglutide | 231 |
| Jardiance Empagliflozin | 200 |
| Metformin Hcl Er Metformin Hcl | 173 |
| Metformin Hcl | 137 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 105 |
| Synthroid Levothyroxine Sodium | 77 |
| Methimazole | 65 |
| Novolog Flexpen Insulin Aspart | 61 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in DE →
All providers in Delaware →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Manveen Duggal, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Manveen Duggal, M.D.'s 3,145 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Delaware
Other clinicians with the same primary specialty enrolled in Delaware, drawn from the same CMS NPPES roster as Duggal.
Samir Ahmed
Seaford, DE
Dr. Hajira Amir
MD
Dover, DE
Dr. Carlton Boxhill
M.D.
Lewes, DE
Dr. Sheetal Bulchandani
MD
Newark, DE
Dr. Suzanne Clough
MD
Wilmington, DE
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Delaware medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Delaware
Frequently Asked Questions
What is Manveen Duggal, M.D.'s specialty? ▼
Manveen Duggal, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Dover, Delaware. Credentials: M.D..
How much does Manveen Duggal, M.D. prescribe under Medicare Part D? ▼
In 2023, Manveen Duggal, M.D. wrote 3,145 Medicare Part D claims totaling $2.6M in drug costs for 411 beneficiaries.
What is Manveen Duggal, M.D.'s Medicare quality score? ▼
Manveen Duggal, M.D. has a CMS MIPS Final Score of 93.3/100 (Quality: 96.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Manveen Duggal, M.D. located? ▼
Manveen Duggal, M.D. is located at 111 WOLF CREEK BLVD STE 3, Dover, DE, 19901. Phone: (302) 734-2782.
What is Manveen Duggal, M.D.'s NPI number? ▼
Manveen Duggal, M.D.'s National Provider Identifier (NPI) is 1538102686, issued on 06/14/2006.
Does Manveen Duggal, M.D. prescribe more brand-name or generic drugs? ▼
Manveen Duggal, M.D.'s prescribing is 57% brand-name and 33% generic drugs by claim count, with $2.5M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Manveen Duggal, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Manveen Duggal, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Trulicity. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Manveen Duggal, M.D. accept Medicare? ▼
Manveen Duggal, M.D. appears in CMS Medicare data with 3,145 Part D claims and 411 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Manveen Duggal, M.D.'s credentials? ▼
Manveen Duggal, M.D.'s NPI is 1538102686 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.